Latent_JJ Herpes_NP Simplex_NP Virus_NP Infection_NP of_IN Sensory_NP Neurons_NP Alters_NP Neuronal_NP Gene_NP Expression_NP The_DT persistence_NN of_IN herpes_NN simplex_JJ virus_NN (_( HSV_NP )_) and_CC the_DT diseases_NNS that_IN it_PP causes_VBZ in_IN the_DT human_JJ population_NN can_MD be_VB attributed_VBN to_TO the_DT maintenance_NN of_IN a_DT latent_JJ infection_NN within_IN neurons_NNS in_IN sensory_JJ ganglia_NNS ._SENT Little_RB is_VBZ known_VBN about_IN the_DT effects_NNS of_IN latent_JJ infection_NN on_IN the_DT host_NN neuron_NN ._SENT We_PP have_VBP addressed_VBN the_DT question_NN of_IN whether_IN latent_JJ HSV_NP infection_NN affects_VBZ neuronal_JJ gene_NN expression_NN by_IN using_VBG microarray_NN transcript_NN profiling_VBG of_IN host_NN gene_NN expression_NN in_IN ganglia_NNS from_IN latently_RB infected_JJ versus_CC mock-infected_JJ mouse_NN trigeminal_JJ ganglia_NNS ._SENT 33P-labeled_JJ cDNA_NN probes_NNS from_IN pooled_JJ ganglia_NNS harvested_VBN at_IN 30_CD days_NNS postinfection_NN or_CC post-mock_NN infection_NN were_VBD hybridized_VBN to_TO nylon_NN arrays_NNS printed_VBN with_IN 2,556_CD mouse_NN genes_NNS ._SENT Signal_NN intensities_NNS were_VBD acquired_VBN by_IN phosphorimager_NN ._SENT Mean_JJ intensities_NNS (_( n_NN =_SYM 4_CD replicates_VBZ in_IN each_DT of_IN three_CD independent_JJ experiments_NNS )_) of_IN signals_NNS from_IN mock-infected_JJ versus_CC latently_RB infected_JJ ganglia_NNS were_VBD compared_VBN by_IN using_VBG a_DT variant_NN of_IN Student_NP 's_POS t_NN test_NN ._SENT We_PP identified_VBD significant_JJ changes_NNS in_IN the_DT expression_NN of_IN mouse_NN neuronal_JJ genes_NNS ,_, including_VBG several_JJ with_IN roles_NNS in_IN gene_NN expression_NN ,_, such_JJ as_IN the_DT Clk2_NP gene_NN ,_, and_CC neurotransmission_NN ,_, such_JJ as_IN genes_NNS encoding_VBG potassium_NN voltage-gated_JJ channels_NNS and_CC a_DT muscarinic_NN acetylcholine_NN receptor_NN ._SENT We_PP confirmed_VBD the_DT neuronal_JJ localization_NN of_IN some_DT of_IN these_DT transcripts_NNS by_IN using_VBG in_IN situ_NN hybridization_NN ._SENT To_TO validate_VB the_DT microarray_NN results_NNS ,_, we_PP performed_VBD real-time_JJ reverse_JJ transcriptase_NN PCR_NP analyses_NNS for_IN a_DT selection_NN of_IN the_DT genes_NNS ._SENT These_DT studies_NNS demonstrate_VBP that_IN latent_JJ HSV_NP infection_NN can_MD alter_VB neuronal_JJ gene_NN expression_NN and_CC might_MD provide_VB a_DT new_JJ mechanism_NN for_IN how_WRB persistent_JJ viral_JJ infection_NN can_MD cause_VB chronic_JJ disease_NN ._SENT A_DT fascinating_JJ attribute_NN of_IN herpes_NN simplex_JJ virus_NN (_( HSV_NP )_) is_VBZ its_PP$ ability_NN to_TO enter_VB a_DT quiescent_JJ state_NN and_CC establish_VB a_DT lifelong_JJ latent_JJ infection_NN in_IN sensory_JJ neurons_NNS that_WDT innervate_VBP the_DT site_NN of_IN primary_JJ ,_, productive_JJ infection_NN ._SENT Following_VBG productive_JJ infection_NN by_IN HSV_NP at_IN the_DT site_NN of_IN inoculation_NN ,_, the_DT virus_NN spreads_NNS to_TO and_CC enters_VBZ sensory_JJ neurons_NNS ,_, where_WRB it_PP establishes_VBZ a_DT latent_JJ infection_NN ._SENT Latent_JJ infection_NN forms_VBZ a_DT reservoir_NN of_IN virus_NN for_IN recurrent_JJ infection_NN ,_, disease_NN ,_, and_CC transmission_NN to_TO other_JJ individuals_NNS ._SENT HSV_NP type_NN 1_CD (_( HSV-1_NP )_) is_VBZ usually_RB associated_VBN with_IN primary_JJ infections_NNS of_IN the_DT orofacial_JJ area_NN and_CC latent_JJ infection_NN of_IN the_DT trigeminal_JJ ganglion_NN ,_, while_IN HSV-2_NP is_VBZ usually_RB associated_VBN with_IN genital_JJ infections_NNS and_CC latent_JJ infection_NN in_IN sacral_JJ ganglia_NNS ._SENT Although_IN both_DT primary_JJ and_CC recurrent_JJ infections_NNS are_VBP usually_RB self-limited_JJ ,_, HSV_NP can_MD cause_VB serious_JJ diseases_NNS such_JJ as_IN neonatal_JJ disseminated_VBN herpes_NN ,_, viral_JJ encephalitis_NN ,_, and_CC blinding_VBG keratitis_NN ._SENT Also_RB ,_, genital_JJ herpes_NN infection_NN has_VBZ been_VBN associated_VBN with_IN an_DT increased_VBN risk_NN for_IN human_JJ immunodeficiency_NN virus_NN infection_NN ._SENT Additionally_RB ,_, long-term_JJ neurological_JJ symptoms_NNS have_VBP occasionally_RB been_VBN associated_VBN with_IN HSV_NP infection_NN ._SENT Latent_JJ HSV_NP infection_NN entails_VBZ repression_NN of_IN the_DT productive_JJ cycle_NN of_IN gene_NN expression_NN ._SENT Although_IN the_DT viral_JJ locus_NN encoding_VBG the_DT latency-associated_JJ transcripts_NNS (_( LATs_NP )_) contributes_VBZ to_TO this_DT repression_NN ,_, host_NN functions_NNS are_VBP also_RB likely_JJ to_TO play_VB a_DT role_NN in_IN the_DT repression_NN of_IN viral_JJ gene_NN expression_NN ._SENT In_IN mouse_NN models_NNS of_IN latent_JJ HSV_NP infection_NN ,_, the_DT presence_NN of_IN infiltrating_VBG immune_JJ cells_NNS and_CC cytokines_NNS in_IN latently_RB infected_JJ ganglia_NNS suggests_VBZ that_IN a_DT local_JJ immune_JJ response_NN may_MD contribute_VB to_TO the_DT maintenance_NN of_IN latent_JJ infection_NN ._SENT Low-level_JJ expression_NN of_IN productive-cycle_NN genes_NNS during_IN latency_NN may_MD provide_VB an_DT antigenic_JJ stimulus_NN for_IN immune_JJ effectors_NNS that_WDT could_MD repress_VB HSV_NP gene_NN expression_NN ._SENT Some_DT evidence_NN suggests_VBZ that_IN neuronal_JJ functions_NNS also_RB help_VBP maintain_VB latency_NN ._SENT Thus_RB ,_, latent_JJ HSV_NP infection_NN appears_VBZ to_TO involve_VB functions_NNS encoded_VBN by_IN the_DT pathogen_NN and_CC host_NN functions_NNS including_VBG nonspecific_JJ and_CC specific_JJ immune_JJ responses_NNS and_CC neuronal_JJ functions_NNS ._SENT Control_NN of_IN transcription_NN is_VBZ likely_JJ to_TO be_VB a_DT central_JJ process_NN in_IN the_DT molecular_JJ interactions_NNS between_IN HSV_NP and_CC its_PP$ mammalian_JJ host_NN ._SENT Transcript_NN profiling_VBG with_IN DNA_NN microarrays_NNS provides_VBZ an_DT opportunity_NN to_TO identify_VB host_NN genes_NNS whose_WP$ expression_NN is_VBZ affected_VBN by_IN the_DT presence_NN of_IN a_DT latent_JJ HSV_NP infection_NN ._SENT Subsequent_JJ analyses_NNS of_IN these_DT genes_NNS could_MD potentially_RB deepen_VB our_PP$ understanding_NN of_IN specific_JJ mechanisms_NNS of_IN virus-host_NN interactions_NNS ._SENT Microarrays_NNS have_VBP been_VBN used_VBN to_TO study_VB productive_JJ HSV_NP infection_NN in_IN cell_NN culture_NN ,_, both_CC to_TO monitor_VB viral_JJ gene_NN expression_NN and_CC to_TO detect_VB HSV-induced_JJ changes_NNS in_IN cellular_JJ gene_NN expression_NN ._SENT Microarray_NP approaches_NNS have_VBP also_RB been_VBN used_VBN to_TO identify_VB changes_NNS in_IN cellular_JJ gene_NN expression_NN under_IN conditions_NNS known_VBN to_TO reactivate_VB HSV_NP from_IN latent_JJ infection_NN in_IN experimental_JJ animal_NN models_NNS ._SENT However_RB ,_, changes_NNS in_IN host_NN gene_NN expression_NN during_IN the_DT maintenance_NN of_IN latency_NN were_VBD not_RB reported_VBN in_IN these_DT studies_NNS ._SENT Analysis_NN of_IN gene_NN expression_NN in_IN infected_JJ tissues_NNS by_IN using_VBG microarrays_NNS can_MD be_VB complicated_VBN greatly_RB by_IN cellular_JJ heterogeneity_NN ._SENT Latent_JJ HSV_NP genomes_NNS reside_VBP in_IN the_DT nuclei_NNS of_IN neuron_NN cell_NN bodies_NNS in_IN trigeminal_JJ ganglia_NNS ._SENT However_RB ,_, trigeminal_JJ ganglia_NNS comprise_VBP not_RB only_JJ clusters_NNS of_IN sensory_JJ neurons_NNS and_CC their_PP$ nerve_NN fibers_NNS but_CC also_RB nerve_NN fibers_NNS derived_VBN from_IN cells_NNS located_VBN outside_IN the_DT trigeminal_JJ ganglion_NN that_WDT pass_VBP through_RP or_CC terminate_VB within_IN the_DT ganglion_NN and_CC small_JJ glial_NN cells_NNS called_VBD satellite_JJ cells_NNS that_WDT completely_RB envelop_VBP the_DT neuronal_JJ cell_NN bodies_NNS ._SENT Also_RB contained_VBN in_IN trigeminal_JJ ganglia_NNS are_VBP Schwann_NP cells_NNS ,_, endothelial_JJ (_( capsular_NN )_) cells_NNS of_IN the_DT microvasculature_NN ,_, blood_NN cells_NNS ,_, and_CC motor_NN neurons_NNS ._SENT During_IN the_DT first_JJ several_JJ days_NNS following_VBG corneal_JJ inoculation_NN of_IN mice_NNS with_IN HSV_NP ,_, the_DT virus_NN replicates_VBZ in_IN corneal_JJ epithelial_JJ cells_NNS and_CC is_VBZ then_RB cleared_VBN by_IN the_DT host_NN immune_JJ response_NN ._SENT During_IN this_DT period_NN ,_, HSV_NP enters_VBZ nerve_NN terminals_NNS and_CC is_VBZ transported_VBN to_TO neuronal_JJ cell_NN bodies_NNS ,_, where_WRB it_PP undergoes_VBZ acute_JJ replication_NN ._SENT Nonspecific_JJ and_CC specific_JJ immune_JJ effector_NN cells_NNS infiltrate_VBP along_IN the_DT trigeminal_JJ nerve_NN and_CC form_NN foci_NNS around_IN individual_JJ infected_JJ neurons_NNS ._SENT Although_IN viral_JJ replication_NN is_VBZ not_RB detectable_JJ and_CC most_JJS infiltrating_VBG cells_NNS are_VBP cleared_VBN by_IN 30_CD days_NNS after_IN corneal_JJ inoculation_NN ,_, low_JJ levels_NNS of_IN immune_JJ effector_NN cells_NNS remain_VBP in_IN ganglia_NNS harboring_VBG latent_JJ HSV_NP ._SENT We_PP set_VBD out_RP to_TO use_VB microarrays_NNS to_TO test_VB the_DT hypothesis_NN that_IN HSV_NP perturbs_VBZ host_NN gene_NN expression_NN in_IN latently_RB infected_JJ ganglia_NNS ._SENT To_TO address_VB the_DT challenge_NN of_IN identifying_VBG gene_NN expression_NN changes_NNS in_IN neurons_NNS that_WDT harbor_VBP latent_JJ HSV_NP within_IN the_DT context_NN of_IN a_DT complex_JJ tissue_NN ,_, we_PP have_VBP performed_VBN microarray_NN analyses_NNS in_IN replicate_JJ experiments_NNS and_CC applied_VBN statistical_JJ tests_NNS to_TO identify_VB those_DT host_NN genes_NNS whose_WP$ expression_NN changes_VBZ significantly_RB with_IN latent_JJ HSV_NP infection_NN ._SENT We_PP found_VBD significant_JJ changes_NNS in_IN the_DT expression_NN of_IN the_DT immune_JJ response_NN and_CC ,_, of_IN particular_JJ interest_NN ,_, in_IN the_DT expression_NN of_IN neuronal_JJ genes_NNS ,_, including_VBG several_JJ with_IN roles_NNS in_IN the_DT regulation_NN of_IN gene_NN expression_NN and_CC neural_JJ transmission_NN ._SENT Cells_NNS and_CC virus_NN ._SENT |_SYM The_DT KOS_NP strain_NN of_IN HSV_NP was_VBD propagated_VBN and_CC assayed_VBN on_IN Vero_NP cell_NN monolayers_NNS as_IN previously_RB described_VBN ._SENT Infection_NN protocol_NN ._SENT |_SYM Seven-week-old_JJ male_JJ HSD/ICR_NP mice_NNS (_( Harlan_NP Sprague-Dawley_NP )_) were_VBD anesthetized_VBN and_CC either_RB infected_VBN with_IN 2_CD x_SYM 106_CD PFU_NP of_IN HSV_NP per_IN eye_NN or_CC mock_NN infected_VBN with_IN a_DT medium_NN by_IN inoculation_NN onto_IN scarified_VBN corneas_NNS as_IN previously_RB described_VBN ._SENT At_IN the_DT indicated_JJ times_NNS postinoculation_NN ,_, the_DT animals_NNS were_VBD sacrificed_VBN and_CC trigeminal_JJ ganglia_NNS were_VBD removed_VBN ,_, rapidly_RB frozen_VBN in_IN dry_JJ ice_NN ,_, and_CC stored_VBD at_IN -80C_NN ._SENT Mice_NNS were_VBD housed_VBN in_IN accordance_NN with_IN institutional_JJ and_CC National_NP Institutes_NPS of_IN Health_NP (_( NIH_NP )_) guidelines_NNS on_IN the_DT care_NN and_CC use_NN of_IN animals_NNS in_IN research_NN ,_, and_CC all_DT procedures_NNS were_VBD approved_VBN by_IN the_DT Institutional_NP Animal_NP Use_NP Committee_NP of_IN Harvard_NP Medical_NP School_NP ._SENT Microarray_NP hybridization_NN ._SENT |_SYM RNA_NP was_VBD isolated_VBN from_IN trigeminal_JJ ganglia_NNS by_IN using_VBG RNA_NP STAT-60_NP (_( Tel-Test_NP ,_, Friendswood_NP ,_, Tex._NP )_) and_CC was_VBD pooled_VBN for_IN each_DT treatment_NN group_NN ._SENT Synthesis_NN of_IN [_SYM 33P]-labeled_JJ cDNA_NN ,_, hybridization_NN conditions_NNS ,_, and_CC data_NNS collection_NN were_VBD exactly_RB as_RB described_VBN previously_RB ,_, except_IN for_IN the_DT use_NN of_IN mouse_NN total_NN RNA_NP (_( 15_CD mug_NN )_) and_CC mouse_NN C0t_NP 10_CD DNA_NN (_( 10_CD mug_NN )_) in_IN hybridizations_NNS to_TO mouse_VB cDNA_NN arrays_NNS ._SENT Array_NN hybridizations_NNS performed_VBN in_IN duplicate_NN were_VBD highly_RB reproducible_JJ ,_, as_RB reflected_VBN by_IN the_DT fact_NN that_IN the_DT coefficient_NN of_IN variation_NN (_( calculated_VBN as_IN the_DT standard_JJ deviation_NN divided_VBN by_IN the_DT mean_NN )_) averaged_VBD less_JJR than_IN 0.2_CD for_IN genes_NNS whose_WP$ intensities_NNS were_VBD above_IN a_DT detection_NN threshold_NN ,_, as_RB reported_VBN by_IN Chiang_NP et_FW al._FW ._SENT The_DT dynamic_JJ range_NN of_IN detection_NN spanned_VBD 3_CD orders_NNS of_IN magnitude_NN ._SENT Spot_NN intensities_NNS were_VBD normalized_VBN to_TO the_DT median_JJ array_NN spot_NN intensity_NN for_IN each_DT individual_JJ filter_NN (_( global_JJ normalization_NN )_) ._SENT Data_NP preprocessing_NN was_VBD performed_VBN ,_, and_CC scatterplots_NNS were_VBD generated_VBN with_IN Expression_NP Explorer_NP (_( Millennium_NP proprietary_JJ software_NN )_) ._SENT Statistical_JJ analysis_NN ._SENT |_SYM To_TO obtain_VB estimates_NNS of_IN measurement_NN error_NN ,_, we_PP assumed_VBD an_DT error_NN model_NN with_IN a_DT fixed_VBN error_NN component_NN (_( e.g._FW ,_, background_NN variation_NN )_) and_CC a_DT proportional_JJ error_NN component_NN (_( e.g._FW ,_, variation_NN in_IN the_DT amount_NN of_IN spotted_JJ DNA_NN )_) ._SENT Measurement_NN error_NN (_( E_NP )_) was_VBD modeled_VBN separately_RB for_IN each_DT group_NN of_IN arrays_NNS corresponding_JJ to_TO an_DT individual_JJ tissue_NN sample_NN ._SENT We_PP modeled_VBD the_DT fixed_VBN error_NN (_( A_NP )_) as_IN being_VBG the_DT median_JJ standard_JJ deviation_NN of_IN the_DT expression_NN level_NN for_IN genes_NNS in_IN the_DT 5th_JJ percentile_NN of_IN expression_NN (_( an_DT average_NN over_RB replicates_VBZ )_) and_CC the_DT coefficient_NN for_IN proportional_JJ error_NN (_( C_NP )_) as_IN the_DT coefficient_NN of_IN variation_NN (_( standard_JJ deviation/mean_NN )_) for_IN genes_NNS in_IN the_DT 95th_JJ percentile_NN of_IN mean_JJ expression_NN ._SENT The_DT measurement_NN error_NN estimate_NN for_IN each_DT gene_NN within_IN each_DT group_NN of_IN arrays_NNS from_IN a_DT given_VBN sample_NN was_VBD then_RB calculated_VBN as_RB ,_, where_WRB A_NP and_CC C_NP are_VBP defined_VBN above_IN and_CC x_NN is_VBZ the_DT replicate-averaged_JJ expression_NN level_NN of_IN the_DT gene_NN ._SENT The_DT observed_JJ standard_JJ deviation_NN was_VBD then_RB regularized_VBN with_IN the_DT estimated_JJ measurement_NN error_NN by_IN using_VBG the_DT method_NN of_IN Baldi_NP and_CC Long_NP with_IN their_PP$ default_NN value_NN of_IN 10_CD pseudocounts_NNS ._SENT For_IN each_DT gene_NN in_IN each_DT of_IN the_DT three_CD independent_JJ experiments_NNS ,_, we_PP obtained_VBD a_DT P_NN value_NN from_IN the_DT two-sided_JJ Student_NN t_NN test_NN comparing_VBG latently_RB infected_JJ and_CC mock-infected_JJ samples_NNS ._SENT The_DT P_NN values_NNS from_IN independent_JJ experiments_NNS were_VBD then_RB combined_VBN by_IN using_VBG Fisher_NP 's_POS method_NN ._SENT A_DT Bonferroni_NP correction_NN based_VBN on_IN the_DT number_NN of_IN genes_NNS tested_VBN was_VBD then_RB applied_VBN so_RB that_IN the_DT single-hypothesis-test_NN P_NN value_NN corresponding_JJ to_TO a_DT significant_JJ difference_NN (_( multiple-hypothesis-corrected_JJ alpha_NN =_SYM 0.05_CD )_) was_VBD <=_NP 9.78_CD x_SYM 10-6_CD and_CC that_IN for_IN a_DT highly_RB significant_JJ difference_NN (_( multiple-hypothesis-corrected_JJ alpha_NN =_SYM 0.001_CD )_) was_VBD <=_NP 1.96_CD x_SYM 10-7_CD ._SENT Although_IN Bonferroni_NP 's_POS correction_NN can_MD be_VB overly_RB conservative_JJ for_IN certain_JJ analyses_NNS ,_, its_PP$ use_NN here_RB is_VBZ consistent_JJ with_IN the_DT primary_JJ goal_NN of_IN determining_VBG with_IN high_JJ confidence_NN whether_IN or_CC not_RB latent_JJ HSV_NP impacts_NNS gene_NN expression_NN in_IN the_DT host_NN ganglion_NN ,_, as_RB opposed_VBN to_TO a_DT goal_NN of_IN generating_VBG a_DT list_NN of_IN hypothetically_RB differentially_RB expressed_VBN genes_NNS with_IN high_JJ false-positive_JJ rates_NNS ._SENT In_IN situ_JJ hybridization_NN |_SYM Methods_NNS for_IN ganglion_NN tissue_NN preparation_NN and_CC in_IN situ_NN hybridization_NN have_VBP been_VBN described_VBN previously_RB ._SENT Plasmids_NNS used_VBN as_IN probes_NNS for_IN cellular_JJ gene_NN expression_NN included_VBD cDNAs_NNS encoding_VBG Chrm1_NP ,_, Ptprs_NP ,_, and_CC Kcnc1_NP ._SENT These_DT genes_NNS were_VBD selected_VBN on_IN the_DT basis_NN of_IN their_PP$ known_VBN neuronal_JJ specificity_NN and_CC the_DT availability_NN of_IN specific_JJ reagents_NNS at_IN the_DT time_NN the_DT tests_NNS were_VBD conducted_VBN ._SENT Plasmid_NP pIPH_NN ,_, used_VBN as_IN a_DT probe_NN for_IN HSV_NP LATs_NP ,_, was_VBD included_VBN with_IN each_DT analysis_NN to_TO confirm_VB latent_JJ or_CC mock_JJ infection_NN in_IN ganglia_NNS and_CC to_TO verify_VB the_DT neuronal_JJ localization_NN of_IN HSV_NP ._SENT DNA_NP probes_NNS were_VBD generated_VBN by_IN radiolabeling_VBG plasmids_NNS with_IN alpha-35S-dATP_NN and_CC alpha-35S-dCTP_NN (_( Amersham_NP ,_, Arlington_NP Heights_NP ,_, Ill._NP )_) via_IN nick_NN translation_NN ._SENT Two_CD to_TO six_CD mock-infected_JJ or_CC latently_RB HSV_NP infected_VBD ganglia_NNS were_VBD serially_RB cryosectioned_JJ (_( thickness_NN ,_, 6_CD mum_NN )_) ._SENT Sequential_JJ sections_NNS from_IN at_IN least_JJS four_CD different_JJ locations_NNS in_IN each_DT ganglion_NN were_VBD hybridized_VBN with_IN the_DT various_JJ probes_NNS described_VBN above_IN ._SENT Real-time_JJ RT-PCR_NP ._SENT |_SYM Real-time_JJ reverse_JJ transcriptase_NN PCR_NP (_( RT-PCR_NP )_) was_VBD performed_VBN on_IN the_DT ABI_NP Prism_NN 7700_CD Sequence_NP Detection_NP system_NN (_( Applied_NP Biosystems_NP ,_, Foster_NP City_NP ,_, Calif._NP )_) ._SENT Primers_NNS were_VBD designed_VBN according_VBG to_TO the_DT manufacturer_NN 's_POS guidelines_NNS ._SENT Aliquots_NNS of_IN RNA_NP from_IN each_DT sample_NN of_IN pooled_JJ ganglia_NNS were_VBD treated_VBN extensively_RB with_IN RQ1_NP DNase_NP ,_, purified_VBN by_IN using_VBG a_DT MasterPure_NP RNA_NP Purification_NP kit_NN (_( Epicentre_NP Technologies_NP ,_, Madison_NP ,_, Wis._NP )_) ,_, and_CC reverse_RB transcribed_VBN with_IN a_DT mixture_NN of_IN gene-specific_NN downstream_IN PCR_NP primers_NNS ._SENT PCR_NP primers_NNS were_VBD based_VBN on_IN clone_NN sequences_NNS and_CC homology_NN data_NNS retrieved_VBN from_IN the_DT Mouse_NP Genome_NP Database_NP ._SENT We_PP used_VBD SYBR_NP Green_NP fluorescence_NN detection_NN for_IN all_DT assays_NNS (_( 2x_NP PCR_NP Master_NP Mix_NP ;_: Applied_NP Biosystems_NP )_) ._SENT The_DT specificity_NN of_IN each_DT assay_NN was_VBD verified_VBN by_IN electrophoretic_JJ separation_NN of_IN exponential-phase_JJ PCR_NP products_NNS on_IN polyacrylamide_NN gels_NNS stained_VBN with_IN a_DT SYBR_NP Gold_NP nucleic_JJ acid_NN gel_NN stain_NN (_( Molecular_NP Probes_NP ,_, Eugene_NP ,_, Oreg_NP ._SENT )_) ._SENT Each_DT set_NN of_IN samples_NNS analyzed_VBD included_VBN cDNAs_NNS derived_VBN from_IN mock-_NN and_CC HSV-infected_JJ samples_NNS from_IN a_DT given_VBN experiment_NN ,_, RT-negative_JJ controls_NNS ,_, and_CC a_DT panel_NN of_IN primer_JJR pairs_NNS that_WDT always_RB included_VBD those_DT for_IN mouse_NN glyceraldehyde-3-phosphate_NN dehydrogenase_NN (_( Gapdh_NP )_) and_CC LAT_NP ._SENT Gapdh_NP was_VBD used_VBN as_IN the_DT normalization_NN standard_NN after_IN it_PP was_VBD determined_VBN that_IN the_DT amounts_NNS of_IN mouse_NN Gapdh_NP RNA_NP per_IN total_JJ RNA_NP measured_VBD spectrophotometrically_RB were_VBD comparable_JJ in_IN the_DT latently_RB infected_JJ and_CC mock-infected_JJ samples_NNS ._SENT LAT_NN was_VBD included_VBN to_TO confirm_VB the_DT identities_NNS of_IN latently_RB versus_IN mock-infected_JJ samples_NNS ._SENT Threshold_NN cycle_NN numbers_NNS (_( CT_NP )_) for_IN each_DT specific_JJ and_CC reference_NN (_( Gapdh_NP )_) cDNA_NN within_IN a_DT given_VBN sample_NN were_VBD measured_VBN at_IN least_JJS twice_RB in_IN duplicate_NN or_CC triplicate_NN from_IN each_DT of_IN two_CD cDNA_NN preparations_NNS of_IN a_DT given_VBN RNA_NP sample_NN ._SENT Replicate_JJ CTs_NNS were_VBD within_IN 1_CD CT_NP of_IN each_DT other_JJ ._SENT CTs_NNS were_VBD averaged_VBN (_( AvCT_NP )_) ._SENT CT_NP is_VBZ inversely_RB proportional_JJ to_TO the_DT amount_NN of_IN starting_VBG material_NN and_CC represents_VBZ a_DT power_NN of_IN 2_CD ;_: the_DT amount_NN is_VBZ calculated_VBN as_IN 1/(2f)-CT_JJ ,_, where_WRB f_NN is_VBZ amplification_NN efficiency_NN ._SENT Based_VBN on_IN the_DT assumption_NN that_IN each_DT sequence_NN was_VBD amplified_VBN with_IN comparable_JJ efficiency_NN in_IN all_DT mock-_NN and_CC HSV-infected_JJ pairs_NNS of_IN samples_NNS ,_, the_DT difference_NN between_IN the_DT AvCT_NN of_IN the_DT reference_NN gene_NN and_CC that_IN of_IN the_DT specific_JJ gene_NN (_( DeltaCT_NP )_) [_SYM AvCT(Gapdh)_NP -_: AvCT(specific_JJ gene_NN )_) =_SYM DeltaCT(specific_JJ gene_NN )_) ]_SYM inversely_RB correlates_NNS with_IN the_DT relative_JJ amount_NN of_IN the_DT specific_JJ gene_NN in_IN a_DT given_VBN sample_NN ._SENT To_TO compare_VB genes_NNS in_IN mock-_NN and_CC HSV-infected_JJ samples_NNS within_IN each_DT of_IN the_DT three_CD experimental_JJ sets_NNS ,_, the_DT difference_NN between_IN their_PP$ DeltaCTs_NP was_VBD determined_VBN [_SYM DeltaCT(gene_NN in_IN mock-infected_JJ sample_NN )_) -_: DeltaCT(gene_NP in_IN HSV-infected_NP sample_NN )_) =_SYM DeltaCT(infection)_NP ]_SYM ._SENT The_DT ratio_NN of_IN gene_NN expression_NN in_IN HSV-infected_JJ samples_NNS to_TO that_DT in_IN mock-infected_JJ samples_NNS is_VBZ calculated_VBN as_IN 2DeltaCT(infection)_JJ for_IN each_DT experimental_JJ set_NN ._SENT Microarray_NN analysis_NN of_IN host_NN gene_NN expression_NN in_IN latently_RB infected_JJ ganglia_NNS ._SENT |_SYM We_PP hypothesized_VBD that_IN latent_JJ HSV_NP infection_NN alters_VBZ neuronal_JJ gene_NN expression_NN in_IN ways_NNS that_WDT might_MD affect_VB neuronal_JJ physiology_NN and_CC viral_JJ gene_NN expression_NN ._SENT To_TO investigate_VB whether_IN latent_JJ HSV_NP infection_NN alters_VBZ neuronal_JJ gene_NN expression_NN ,_, we_PP conducted_VBD transcript_NN profiling_VBG using_VBG microarray_NN technology_NN ._SENT We_PP used_VBD a_DT well-characterized_JJ mouse_NN model_NN in_IN which_WDT HSV-1_NP strain_NN KOS_NP is_VBZ inoculated_VBN onto_IN a_DT scarified_VBN mouse_NN cornea_NN ,_, undergoes_VBZ productive_JJ infection_NN in_IN the_DT corneal_JJ epithelium_NN and_CC trigeminal_JJ ganglion_NN for_IN several_JJ days_NNS ,_, and_CC then_RB establishes_VBZ a_DT latent_JJ infection_NN in_IN trigeminal_JJ ganglia_NNS by_IN day_NN 30_CD postinoculation_NN ._SENT RNA_NP was_VBD prepared_VBN from_IN pooled_JJ ganglia_NNS (_( 10_CD to_TO 16_CD for_IN each_DT sample_NN )_) harvested_VBN as_IN described_VBN previously_RB at_IN day_NN 30_CD postinfection_NN (_( p.i._JJ )_) ._SENT RNA_NP samples_NNS from_IN latently_RB and_CC mock-infected_JJ mice_NNS were_VBD used_VBN to_TO generate_VB radiolabeled_JJ cDNA_NN probes_NNS ._SENT Probes_NNS were_VBD hybridized_VBN to_TO duplicate_VB nylon_NN filters_NNS ,_, with_IN each_DT printed_VBN in_IN duplicate_NN with_IN 2,556_CD PCR-amplified_JJ ,_, mostly_RB full_JJ length_NN mouse_NN cDNA_NN clones_NNS plus_CC quality_NN and_CC normalization_NN control_NN clones_NNS ._SENT Scatterplots_NNS of_IN duplicate_JJ hybridizations_NNS demonstrated_VBD the_DT filter-to-filter_NN consistency_NN of_IN the_DT arrays_NNS ,_, while_IN scatterplots_NNS of_IN latently_RB infected_JJ versus_CC mock-infected_JJ ganglia_NNS revealed_VBD numerous_JJ differences_NNS consistent_JJ with_IN increases_NNS and_CC decreases_NNS in_IN host_NN transcript_NN levels_NNS ._SENT Thus_RB ,_, differences_NNS in_IN gene_NN expression_NN between_IN the_DT experimental_JJ and_CC control_NN groups_NNS were_VBD detected_VBN by_IN microarray_NN analysis_NN ._SENT Several_JJ factors_NNS could_MD potentially_RB limit_VB the_DT confidence_NN with_IN which_WDT one_CD can_MD interpret_VB microarray_NN results_NNS ._SENT First_RB ,_, there_EX is_VBZ experimental_JJ variability_NN of_IN microarray_NN measurements_NNS ,_, as_RB has_VBZ been_VBN observed_VBN by_IN others_NNS ._SENT Second_RB ,_, only_RB a_DT small_JJ fraction_NN of_IN cells_NNS in_IN trigeminal_JJ ganglia_NNS harbor_VBP latent_JJ HSV_NP ,_, so_RB that_DT even_RB large_JJ differences_NNS in_IN gene_NN expression_NN in_IN individual_JJ infected_JJ cells_NNS might_MD give_VB rise_VB to_TO very_RB small_JJ differences_NNS in_IN expression_NN on_IN a_DT whole-ganglion_NN basis_NN ._SENT Thus_RB ,_, we_PP wished_VBD to_TO evaluate_VB relatively_RB small_JJ differences_NNS in_IN gene_NN expression_NN ._SENT For_IN these_DT reasons_NNS ,_, we_PP performed_VBD three_CD independent_JJ experiments_NNS that_WDT entailed_VBD three_CD separate_JJ infections_NNS of_IN mice_NNS and_CC preparation_NN of_IN cDNA_NN probes_NNS to_TO increase_VB the_DT statistical_JJ power_NN of_IN the_DT analysis_NN ._SENT Microarray_NN sets_NNS used_VBN for_IN each_DT experiment_NN came_VBD from_IN separate_JJ printings_NNS ._SENT Each_DT probe_NN was_VBD hybridized_VBN on_IN replicate_JJ arrays_NNS such_JJ that_IN each_DT clone_NN was_VBD represented_VBN at_IN least_JJS four_CD times_NNS ._SENT Differences_NNS between_IN latently_RB HSV_NP infected_JJ and_CC mock-infected_JJ samples_NNS were_VBD evaluated_VBN statistically_RB in_IN each_DT experiment_NN by_IN using_VBG a_DT variant_NN of_IN the_DT Student_NP t_NN test_NN in_IN which_WDT standard_JJ deviations_NNS were_VBD regularized_VBN by_IN an_DT independent_JJ estimate_NN of_IN measurement_NN errors_NNS ._SENT The_DT P_NN values_VBZ from_IN each_DT experiment_NN were_VBD combined_VBN ,_, and_CC a_DT correction_NN was_VBD applied_VBN to_TO account_VB for_IN the_DT total_JJ number_NN of_IN genes_NNS tested_VBN ._SENT Only_JJ genes_NNS whose_WP$ expression_NN differed_VBD in_IN the_DT same_JJ direction_NN in_IN all_DT three_CD experiments_NNS were_VBD included_VBN ._SENT Differences_NNS between_IN latently_RB and_CC mock-infected_JJ samples_NNS were_VBD statistically_RB significant_JJ for_IN 51_CD genes_NNS ,_, and_CC 8_CD of_IN these_DT differences_NNS were_VBD highly_RB significant_JJ (_( Tables_NP and_CC )_) ._SENT (_( The_DT entire_JJ annotated_VBN list_NN of_IN genes_NNS represented_VBN in_IN the_DT data_NNS set_VBP ,_, along_RB with_IN averaged_VBN ,_, normalized_VBN values_NNS and_CC ratios_NNS of_IN gene_NN expression_NN in_IN HSV-infected_JJ samples_NNS to_TO that_DT in_IN mock-infected_JJ samples_NNS ,_, is_VBZ available_JJ for_IN viewing_VBG at_IN ._SENT )_) Altered_JJ expression_NN of_IN immune_JJ response_NN genes_NNS ._SENT |_SYM Infiltration_NN of_IN inflammatory_JJ cells_NNS in_IN latently_RB infected_JJ ganglionic_JJ tissue_NN has_VBZ been_VBN observed_VBN ._SENT Thus_RB ,_, it_PP was_VBD not_RB surprising_JJ that_IN about_IN half_NN of_IN the_DT 51_CD genes_NNS in_IN Tables_NP and_CC are_VBP involved_VBN in_IN the_DT immune_JJ response_NN and_CC that_IN all_DT of_IN these_DT immune_JJ response_NN genes_NNS exhibited_VBD increased_VBN expression_NN in_IN latently_RB infected_JJ versus_CC mock-infected_JJ ganglia_NNS ._SENT This_DT group_NN included_VBD genes_NNS expressed_VBD specifically_RB by_IN immune_JJ cells_NNS ,_, such_JJ as_IN the_DT CD3_NP subunit_NN gene_NN Cd3g_NP ,_, and/or_CC in_IN target_NN cells_NNS involved_VBN in_IN antigen_NN presentation_NN or_CC in_IN responding_VBG to_TO immune_JJ stimuli_NNS ,_, such_JJ as_IN the_DT major_JJ histocompatibility_NN complex_JJ class_NN I_PP genes_NNS H2-D1_JJ and_CC beta2_JJ microglobulin_NN ,_, which_WDT can_MD be_VB expressed_VBN in_IN the_DT nervous_JJ system_NN ._SENT These_DT results_NNS confirm_VBP and_CC extend_VBP previous_JJ observations_NNS of_IN a_DT persistent_JJ immune_JJ response_NN in_IN latently_RB infected_JJ ganglia_NNS ,_, thus_RB validating_VBG the_DT array_NN results_NNS ._SENT Alteration_NN of_IN neuronal_JJ gene_NN expression_NN ._SENT |_SYM Strikingly_RB ,_, a_DT surprising_JJ number_NN of_IN the_DT genes_NNS in_IN Tables_NP and_CC (_( mostly_RB in_IN Table_NN )_) are_VBP known_VBN to_TO be_VB expressed_VBN in_IN nervous_JJ system_NN tissue_NN and/or_CC neurons_NNS ._SENT Twenty-one_NN genes_NNS of_IN this_DT class_NN exhibited_VBD increased_VBN expression_NN in_IN latently_RB infected_JJ versus_CC mock-infected_JJ ganglia_NNS ,_, and_CC eight_CD exhibited_VBD decreased_VBN expression_NN ._SENT Many_JJ of_IN the_DT genes_NNS whose_WP$ expression_NN was_VBD altered_VBN play_NN definite_JJ roles_NNS in_IN neuronal_JJ physiology_NN ._SENT These_DT include_VBP genes_NNS encoding_VBG neurotransmitter_NN receptors_NNS ,_, such_JJ as_IN Gprc1g_NP ,_, Chrm1_NP ,_, and_CC Gabbr1_NP ;_: voltage-gated_JJ ion_NN channels_NNS ,_, such_JJ as_IN Kcnc1_NP and_CC Kcnab_NP ;_: proteins_NNS involved_VBN in_IN signaling_VBG ,_, including_VBG Trc8_NP ,_, Ptprs_NP ,_, Adrbk1_NP ,_, Gpr56_NP ,_, Ppp3Ca_NP ,_, Rgs4_NP ,_, Rab27b_NP ,_, and_CC Gh_NNS ;_: proteins_NNS involved_VBN in_IN neurite_NN extension_NN ,_, axonal_JJ elongation_NN ,_, and_CC cell-matrix_NN interactions_NNS (_( "_`` axonal_JJ remodeling_NN "_'' )_) ,_, such_JJ as_IN Prss12_NP ,_, Ulk1_NP ,_, Col15a1_NP ,_, Adam23_NP ,_, and_CC n-chimaerin_JJ ;_: and_CC proteins_NNS involved_VBN in_IN catabolic_JJ functions_NNS ,_, such_JJ as_IN Man2b1_NP ,_, Ctsd_NP ,_, Usp20_NP ,_, Ube1x_NP ,_, and_CC Acox2_NP ._SENT Several_JJ genes_NNS ,_, such_JJ as_IN Stat1_NP ,_, Hipk2_NP ,_, Apobec1_NP ,_, and_CC Clk2_NP ,_, are_VBP involved_VBN in_IN gene_NN expression_NN ._SENT One_CD gene_NN ,_, Aebp1_NP ,_, encodes_VBZ a_DT protein_NN described_VBD variously_RB as_IN being_VBG involved_VBN in_IN either_DT gene_NN expression_NN or_CC axonal_JJ remodeling_NN or_CC both_DT ._SENT In_IN situ_NN hybridization_NN analysis_NN was_VBD performed_VBN on_IN a_DT few_JJ genes_NNS that_WDT appeared_VBD significantly_RB altered_VBN in_IN all_DT statistical_JJ analyses_NNS in_IN an_DT attempt_NN to_TO determine_VB the_DT cell_NN types_NNS that_WDT expressed_VBD the_DT cellular_JJ transcripts_NNS ._SENT Neuronal_JJ expression_NN of_IN Chrm1_NP was_VBD observed_VBN in_IN sensory_JJ neurons_NNS in_IN mock-infected_JJ (_( data_NNS not_RB shown_VBN )_) and_CC latently_RB infected_JJ ganglia_NNS ._SENT Neuronal_JJ expression_NN of_IN Ptprs_NNS was_VBD also_RB observed_VBN in_IN mock-infected_JJ (_( data_NNS not_RB shown_VBN )_) and_CC latently_RB infected_JJ ganglia_NNS ._SENT Finally_RB ,_, neuronal_JJ expression_NN of_IN Kcnc_NP 1_CD was_VBD observed_VBN in_IN mock-infected_JJ and_CC latently_RB infected_JJ ganglia_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT We_PP confirmed_VBD that_IN these_DT ganglia_NNS were_VBD latently_RB infected_VBN by_IN in_IN situ_NN hybridization_NN with_IN a_DT LAT_NP probe_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Specific_JJ neuronal_JJ expression_NN of_IN another_DT gene_NN ,_, Stat1_NP ,_, in_IN mouse_NN trigeminal_JJ ganglia_NNS has_VBZ recently_RB been_VBN shown_VBN by_IN immunohistochemistry_NN ._SENT Although_IN expression_NN of_IN Gh_NNS in_IN neurons_NNS has_VBZ not_RB been_VBN documented_VBN to_TO our_PP$ knowledge_NN ,_, the_DT expression_NN of_IN Gh_JJ receptors_NNS and_CC target_NN genes_NNS has_VBZ been_VBN demonstrated_VBN ._SENT Confirmation_NN by_IN real-time_JJ RT-PCR_NP ._SENT |_SYM To_TO verify_VB these_DT changes_NNS in_IN gene_NN expression_NN by_IN an_DT alternate_JJ method_NN ,_, we_PP quantified_VBD the_DT expression_NN of_IN 11_CD genes_NNS (_( Tables_NP and_CC )_) representing_VBG various_JJ neuronal_JJ functions_NNS by_IN RT-PCR_NP using_VBG real-time_JJ technology_NN ._SENT Mouse_NP Gapdh_NP was_VBD assayed_VBN as_IN a_DT normalization_NN control_NN ._SENT As_IN shown_VBN in_IN Fig._NN ,_, Stat1_NP transcripts_NNS ,_, which_WDT were_VBD more_RBR abundant_JJ in_IN latently_RB infected_VBN than_IN in_IN mock-infected_JJ ganglia_NNS in_IN the_DT three_CD array_NN analyses_NNS ,_, were_VBD also_RB reproducibly_RB more_RBR abundant_JJ in_IN latently_RB infected_VBN than_IN in_IN mock-infected_JJ ganglia_NNS relative_JJ to_TO the_DT abundance_NN of_IN Gapdh_NP transcripts_NNS in_IN the_DT RT-PCR_NP assay_NN ._SENT The_DT mean_JJ ratios_NNS of_IN expression_NN in_IN latently_RB infected_VBN ganglia_NNS to_TO expression_NN in_IN mock-infected_JJ ganglia_NNS were_VBD of_IN similar_JJ magnitude_NN by_IN the_DT two_CD assays_NNS ._SENT Thus_RB ,_, we_PP verified_VBD changes_NNS in_IN expression_NN of_IN specific_JJ neuronal_JJ genes_NNS in_IN latently_RB infected_VBN ganglia_NNS by_IN RT-PCR_NP ._SENT Time_NN course_NN of_IN host_NN gene_NN expression_NN ._SENT |_SYM The_DT altered_JJ levels_NNS of_IN specific_JJ mouse_NN RNAs_NP in_IN latently_RB infected_VBN ganglia_NNS on_IN day_NN 30_CD p.i._NN could_MD reflect_VB changes_NNS in_IN cellular_JJ gene_NN expression_NN specific_JJ to_TO the_DT latent_JJ state_NN or_CC changes_NNS induced_VBD initially_RB during_IN acute_JJ viral_JJ replication_NN ._SENT To_TO distinguish_VB between_IN these_DT possibilities_NNS ,_, in_IN one_CD of_IN the_DT three_CD experiments_NNS we_PP harvested_VBD trigeminal_JJ ganglia_NNS from_IN HSV-_NP and_CC mock-infected_JJ mice_NNS on_IN days_NNS 3_CD and_CC 10_CD p.i._NN ,_, and_CC we_PP assayed_VBD the_DT RNA_NP by_IN using_VBG the_DT same_JJ arrays_NNS used_VBN for_IN the_DT 30-day_JJ samples_NNS ._SENT Limiting_VBG the_DT analysis_NN just_RB to_TO the_DT 52_CD genes_NNS in_IN Table_NP ,_, those_DT whose_WP$ expression_NN was_VBD greater_JJR in_IN latently_RB infected_JJ ganglia_NNS formed_VBD two_CD expression_NN profile_NN clusters_NNS :_: one_CD ,_, of_IN special_JJ interest_NN ,_, comprising_VBG 15_CD genes_NNS showing_VBG maximal_JJ expression_NN on_IN day_NN 30_CD p.i._NN (_( Fig._NN and_CC Table_NN )_) and_CC the_DT other_JJ showing_NN maximal_JJ expression_NN on_IN either_DT day_NN 3_CD or_CC day_NN 10_CD p.i._NN (_( Fig._NN and_CC Table_NN )_) ._SENT As_IN expected_VBN ,_, most_JJS of_IN the_DT host_NN immune_JJ response_NN genes_NNS exhibited_VBD peak_JJ expression_NN on_IN day_NN 3_CD or_CC 10_CD p.i._NN ,_, with_IN peak_NN levels_NNS of_IN lymphocyte_NN markers_NNS such_JJ as_IN Cd3d_NP ,_, Cd3g_NP ,_, Cxcr6_NP ,_, Lyn_NP ,_, Axl_NP ,_, Il2rg_NP ,_, Lck_NP ,_, and_CC Ptprc_NP at_IN day_NN 10_CD p.i._NN (_( Many_JJ other_JJ genes_NNS known_VBN to_TO be_VB involved_VBN in_IN classical_JJ host_NN immune_JJ responses_NNS exhibited_VBD increased_VBN expression_NN at_IN days_NNS 3_CD and_CC 10_CD ,_, as_RB expected_VBN ._SENT Only_RB those_DT whose_WP$ expression_NN was_VBD significantly_RB increased_VBN at_IN day_NN 30_CD are_VBP examined_VBN here_RB ._SENT )_) The_DT peak_JJ expression_NN of_IN Stat1_NP on_IN day_NN 3_CD p.i._NNS was_VBD consistent_JJ with_IN high_JJ expression_NN of_IN cytokines_NNS at_IN this_DT time_NN ._SENT In_IN contrast_NN ,_, most_JJS of_IN the_DT genes_NNS that_WDT are_VBP known_VBN to_TO be_VB expressed_VBN relatively_RB abundantly_RB in_IN nervous_JJ tissue_NN and/or_CC neurons_NNS ,_, including_VBG those_DT shown_VBN by_IN in_IN situ_NN hybridization_NN to_TO be_VB specifically_RB expressed_VBN in_IN neurons_NNS of_IN latently_RB infected_VBN trigeminal_JJ ganglia_NNS ,_, were_VBD expressed_VBN in_IN greatest_JJS abundance_NN on_IN day_NN 30_CD p.i._NN ,_, well_RB after_IN cessation_NN of_IN acute_JJ viral_JJ replication_NN in_IN ganglia_NNS ._SENT Additionally_RB ,_, the_DT eight_CD genes_NNS whose_WP$ expression_NN was_VBD lower_JJR in_IN latently_RB infected_JJ ganglia_NNS all_RB exhibited_VBD the_DT greatest_JJS decrease_NN relative_JJ to_TO levels_NNS in_IN mock-infected_JJ ganglia_NNS at_IN day_NN 30_CD p.i._NN ._SENT Thus_RB ,_, taken_VBN together_RB ,_, these_DT data_NNS show_VBP that_IN latent_JJ infection_NN rather_RB than_IN acute_JJ infection_NN was_VBD associated_VBN with_IN altered_JJ expression_NN of_IN these_DT neuronal_JJ genes_NNS ._SENT An_DT important_JJ problem_NN in_IN virology_NN is_VBZ to_TO understand_VB the_DT interaction_NN of_IN latent_JJ viral_JJ infections_NNS with_IN the_DT host_NN cell_NN and_CC to_TO identify_VB host_NN responses_NNS to_TO virus_NN latency_NN ._SENT In_IN these_DT studies_NNS ,_, we_PP observed_VBD up-regulation_NN or_CC down-regulation_NN during_IN latent_JJ infection_NN of_IN the_DT levels_NNS of_IN a_DT number_NN of_IN host_NN genes_NNS ,_, including_VBG several_JJ thought_NN to_TO be_VB expressed_VBN specifically_RB in_IN neurons_NNS ._SENT Our_PP$ confidence_NN that_IN levels_NNS of_IN expression_NN of_IN the_DT genes_NNS listed_VBN in_IN Tables_NP and_CC are_VBP truly_RB altered_VBN is_VBZ based_VBN on_IN stringent_JJ statistical_JJ criteria_NNS applied_VBN to_TO the_DT microarray_NN hybridization_NN data_NNS coupled_VBN with_IN validation_NN by_IN quantitative_JJ real-time_JJ RT-PCR_NP ._SENT Evidence_NN that_IN expression_NN of_IN the_DT genes_NNS listed_VBN in_IN Table_NP is_VBZ altered_VBN only_RB during_IN latent_JJ infection_NN and_CC that_IN these_DT changes_NNS are_VBP not_RB remnants_NNS of_IN acute_JJ infection_NN is_VBZ provided_VBN by_IN the_DT results_NNS in_IN Fig._NN ._SENT In_IN contrast_NN to_TO our_PP$ results_NNS ,_, Hill_NP and_CC colleagues_NNS did_VBD not_RB identify_VB changes_NNS in_IN gene_NN expression_NN between_IN uninfected_JJ and_CC latently_RB infected_JJ ganglia_NNS ._SENT One_CD reason_NN for_IN the_DT differing_VBG results_NNS could_MD be_VB that_IN they_PP looked_VBD at_IN a_DT total_NN of_IN only_RB 149_CD mouse_NN genes_NNS in_IN a_DT "_`` stress/toxicology_NN "_'' set_VBN ,_, whereas_IN our_PP$ data_NNS set_NN included_VBD 2,500_CD genes_NNS in_IN a_DT diverse_JJ set_NN ._SENT Potential_JJ effects_NNS of_IN latent_JJ HSV_NP infection_NN on_IN host_NN gene_NN expression_NN ._SENT |_SYM Our_JJ microarray_NN data_NNS reflect_VBP changes_NNS in_IN gene_NN expression_NN in_IN the_DT entire_JJ trigeminal_JJ ganglion_NN ,_, which_WDT is_VBZ a_DT heterogeneous_JJ tissue_NN composed_VBN of_IN many_JJ cell_NN types_NNS ._SENT The_DT alterations_NNS in_IN expression_NN of_IN neuron-specific_JJ genes_NNS observed_VBN in_IN these_DT studies_NNS could_MD represent_VB a_DT direct_JJ effect_NN of_IN HSV_NP on_IN cellular_JJ gene_NN expression_NN in_IN latently_RB infected_JJ cells_NNS ._SENT Alternatively_RB ,_, the_DT virus_NN may_MD act_VB indirectly_RB on_IN cellular_JJ gene_NN expression_NN ,_, for_IN example_NN ,_, by_IN inducing_VBG neuronal_JJ injury_NN or_CC by_IN inducing_VBG a_DT persistent_JJ immune_JJ response_NN to_TO latent_JJ infection_NN that_WDT includes_VBZ expression_NN of_IN cytokines_NNS known_VBN to_TO alter_VB host_NN gene_NN expression_NN ._SENT The_DT increased_VBN expression_NN of_IN Stat1_NP is_VBZ consistent_JJ with_IN the_DT latter_JJ mechanism_NN ._SENT Although_IN it_PP is_VBZ easier_JJR to_TO explain_VB the_DT decreased_VBN expression_NN of_IN certain_JJ genes_NNS by_IN such_PDT an_DT indirect_JJ mechanism_NN ,_, to_TO date_VB ,_, little_JJ or_CC no_DT precedent_NN exists_VBZ for_IN immune_JJ modulation_NN of_IN neuronal_JJ gene_NN expression_NN ._SENT Direct_JJ and_CC indirect_JJ effects_NNS of_IN latent_JJ HSV_NP infection_NN on_IN cellular_JJ gene_NN expression_NN are_VBP not_RB necessarily_RB mutually_RB exclusive_JJ ._SENT These_DT two_CD mechanisms_NNS make_VBP specific_JJ predictions_NNS about_IN the_DT levels_NNS of_IN expression_NN of_IN particular_JJ cellular_JJ genes_NNS in_IN latently_RB infected_JJ versus_CC uninfected_JJ neurons_NNS ._SENT Preliminary_JJ studies_NNS using_VBG in_IN situ_NN hybridization_NN to_TO examine_VB this_DT issue_NN have_VBP been_VBN inconclusive_JJ due_RB to_TO the_DT qualitative_JJ nature_NN of_IN this_DT technique_NN and_CC the_DT apparent_JJ variability_NN of_IN expression_NN from_IN cell_NN to_TO cell_NN ._SENT Thus_RB ,_, PCR-based_JJ methods_NNS to_TO examine_VB individual_JJ cells_NNS may_MD be_VB necessary_JJ to_TO test_VB these_DT models_NNS ._SENT Potential_JJ effects_NNS of_IN changes_NNS in_IN host_NN gene_NN expression_NN on_IN viral_JJ gene_NN expression_NN ._SENT |_SYM Alternatively_RB ,_, changes_NNS in_IN cellular_JJ gene_NN expression_NN may_MD represent_VB a_DT host_NN response_NN that_WDT contributes_VBZ to_TO the_DT repression_NN of_IN productive-cycle_JJ HSV_NP gene_NN expression_NN characteristic_NN of_IN latent_JJ infection_NN ._SENT Of_IN particular_JJ interest_NN are_VBP cellular_JJ genes_NNS encoding_VBG proteins_NNS that_WDT regulate_VBP gene_NN expression_NN ._SENT Aebp1_NP has_VBZ been_VBN reported_VBN to_TO be_VB a_DT transcriptional_JJ repressor_NN ,_, and_CC Hipk2_NP has_VBZ been_VBN reported_VBN to_TO be_VB a_DT corepressor_NN ._SENT A_DT relative_NN of_IN Clk2_NP ,_, Clk1_NP ,_, has_VBZ been_VBN reported_VBN to_TO induce_VB neuronal_JJ differentiation_NN of_IN PC12_JJ cells_NNS in_IN a_DT manner_NN akin_JJ to_TO nerve_VB growth_NN factor_NN ,_, which_WDT helps_VBZ to_TO maintain_VB HSV_NP latency_NN in_IN both_CC in_IN vitro_NN and_CC in_IN vivo_JJ models_NNS ._SENT The_DT increased_VBN expression_NN of_IN Apobec1_NP ,_, an_DT RNA-editing_NP enzyme_NN ,_, is_VBZ especially_RB intriguing_JJ ,_, given_VBN the_DT abundant_JJ expression_NN of_IN LAT_NP ,_, an_DT RNA_NP of_IN uncertain_JJ coding_VBG capacity_NN ,_, in_IN latently_RB infected_JJ neurons_NNS ._SENT Altered_JJ expression_NN of_IN genes_NNS may_MD provide_VB clues_NNS to_TO changes_NNS in_IN signaling_VBG pathways_NNS that_WDT regulate_VBP gene_NN expression_NN ._SENT The_DT increased_VBN expression_NN of_IN Chrm1_NP is_VBZ interesting_JJ in_IN that_IN it_PP is_VBZ ordinarily_RB down-regulated_JJ by_IN ciliary_JJ neurotrophic_JJ factor_NN (_( CNTF_NP )_) ,_, which_WDT has_VBZ been_VBN reported_VBN to_TO promote_VB HSV_NP reactivation_NN in_IN humans_NNS ._SENT Certain_JJ cellular_JJ genes_NNS may_MD maintain_VB the_DT virus_NN in_IN a_DT state_NN of_IN readiness_NN for_IN reactivation_NN ._SENT Stat1_NP may_MD also_RB be_VB in_IN this_DT category_NN ,_, as_IN it_PP is_VBZ activated_VBN by_IN CNTF_NP ._SENT Other_JJ neuronal_JJ genes_NNS whose_WP$ expression_NN is_VBZ altered_VBN could_MD also_RB influence_VB viral_JJ gene_NN expression_NN less_RBR directly_RB ._SENT For_IN example_NN ,_, Chrm1_JJ couples_NNS to_TO G_NP proteins_NNS that_WDT can_MD activate_VB mitogen-activated_JJ protein_NN kinase_NN cascades_NNS that_WDT lead_VBP to_TO changes_NNS in_IN gene_NN expression_NN ._SENT These_DT various_JJ hypotheses_NNS make_VBP specific_JJ ,_, testable_JJ predictions_NNS regarding_VBG the_DT effects_NNS of_IN knocking_VBG out_RP or_CC overexpressing_VBG these_DT genes_NNS in_IN latently_RB infected_JJ ganglia_NNS ._SENT Cellular_JJ proteins_NNS that_WDT help_VBP to_TO maintain_VB latency_NN or_CC promote_VB reactivation_NN could_MD potentially_RB serve_VB as_IN targets_NNS for_IN therapeutic_JJ intervention_NN ._SENT Potential_JJ implications_NNS for_IN HSV_NP infections_NNS in_IN humans_NNS ._SENT |_SYM Given_VBN that_IN the_DT expression_NN of_IN several_JJ genes_NNS with_IN known_VBN roles_NNS in_IN neurotransmission_NN and_CC signaling_VBG is_VBZ altered_VBN in_IN latently_RB infected_JJ ganglia_NNS ,_, our_PP$ results_NNS ,_, using_VBG a_DT mouse_NN model_NN and_CC a_DT virus_NN strain_NN with_IN which_WDT no_DT spontaneous_JJ reactivation_NN has_VBZ ever_RB been_VBN observed_VBN ,_, raise_VB the_DT possibility_NN that_IN latent_JJ HSV_NP can_MD affect_VB sensation_NN ._SENT Moreover_RB ,_, several_JJ of_IN the_DT genes_NNS whose_WP$ expression_NN is_VBZ altered_VBN ,_, including_VBG Gprc1g_NP ,_, Gabbr1_NP ,_, Kcnab2_NP ,_, and_CC Kcnc1_NP ,_, affect_VBP neuronal_JJ excitability_NN in_IN an_DT interconnected_VBN manner_NN ,_, which_WDT suggests_VBZ a_DT mechanism_NN by_IN which_WDT changes_NNS in_IN neuronal_JJ physiology_NN are_VBP induced_VBN by_IN latent_JJ virus_NN and_CC could_MD alter_VB sensation_NN ._SENT This_DT predicts_VBZ that_IN neurons_NNS in_IN latently_RB infected_JJ ganglia_NNS would_MD exhibit_VB alterations_NNS in_IN ion_NN channel_NN function_VBP such_JJ as_RB have_VB been_VBN observed_VBN in_IN neurons_NNS in_IN vitro_NN ._SENT Consistent_JJ with_IN this_DT idea_NN ,_, postherpetic_JJ allodynia_NNS and_CC hyperalgesia_NNS have_VBP been_VBN observed_VBN in_IN mice_NNS latently_RB infected_VBN with_IN HSV_NP for_IN at_IN least_JJS 40_CD days_NNS p.i._JJ ._SENT Interestingly_RB ,_, there_EX are_VBP reports_NNS of_IN patients_NNS with_IN recurrent_JJ HSV_NP with_IN symptoms_NNS of_IN abnormal_JJ sensation_NN ,_, including_VBG pain_NN ,_, both_CC before_RB and_CC even_RB long_RB after_IN clinically_RB evident_JJ disease_NN ._SENT Although_IN these_DT symptoms_NNS are_VBP often_RB ascribed_VBN to_TO reactivating_VBG HSV_NP ,_, or_CC could_MD be_VB due_JJ to_TO sensory_JJ nerve_NN or_CC central_JJ nervous_JJ system_NN injury_NN ,_, our_PP$ results_NNS provoke_VB the_DT speculation_NN that_IN these_DT clinical_JJ phenomena_NNS and_CC perhaps_RB more_RBR subtle_JJ changes_NNS in_IN sensation_NN may_MD be_VB due_JJ to_TO effects_NNS of_IN latent_JJ HSV_NP infection_NN on_IN sensory_JJ neurons_NNS ._SENT These_DT studies_NNS demonstrate_VBP that_IN latent_JJ herpes_NN simplex_JJ virus_NN infection_NN can_MD alter_VB neuronal_JJ gene_NN expression_NN and_CC might_MD provide_VB a_DT new_JJ mechanism_NN for_IN how_WRB persistent_JJ viral_JJ infection_NN can_MD cause_VB chronic_JJ disease_NN ._SENT Scatterplots_NNS comparing_VBG 33P_JJ signal_NN intensities_NNS in_IN microarrays_NNS after_IN background_NN subtraction_NN and_CC normalization_NN ._SENT Scatterplots_NNS comparing_VBG 33P_JJ signal_NN intensities_NNS in_IN microarrays_NNS after_IN background_NN subtraction_NN and_CC normalization_NN ._SENT Each_DT point_NN represents_VBZ the_DT log10_JJ phosphorimager_NN intensity_NN value_NN normalized_VBD to_TO the_DT median_JJ intensity_NN of_IN the_DT microarray_NN for_IN each_DT filter_NN ._SENT (_( A_DT and_CC B_NN )_) Results_NNS from_IN duplicate_JJ array_NN hybridizations_NNS ._SENT The_DT x_NN and_CC y_NN axes_NNS each_DT represent_VBP one_CD of_IN the_DT two_CD duplicate_JJ arrays_NNS ._SENT HSV_NP ,_, one_CD representative_NN probe_NN generated_VBN from_IN pooled_JJ ganglia_NNS 30_CD days_NNS after_IN infection_NN ._SENT Mock_JJ ,_, one_CD representative_NN probe_NN generated_VBN from_IN pooled_JJ ganglia_NNS 30_CD days_NNS after_IN mock_JJ infection_NN ,_, and_CC from_IN the_DT same_JJ experiment_NN as_IN the_DT HSV_NP probe_NN shown_VBN ._SENT (_( C_LS )_) Results_NNS for_IN HSV-infected_JJ versus_CC mock-infected_JJ ganglia_NNS ._SENT y_NP axis_NN ,_, one_CD of_IN the_DT two_CD duplicate_JJ HSV_NP arrays_NNS ;_: x_SYM axis_NN ,_, one_CD of_IN the_DT duplicate_JJ Mock_NP arrays_NNS ._SENT Neuronal_JJ expression_NN of_IN host_NN genes_NNS confirmed_VBD by_IN in_IN situ_NN hybridization_NN ._SENT Neuronal_JJ expression_NN of_IN host_NN genes_NNS confirmed_VBD by_IN in_IN situ_NN hybridization_NN ._SENT Mouse_NP trigeminal_JJ ganglia_NNS latently_RB infected_VBN with_IN HSV_NP at_IN 30_CD days_NNS p.i._NN hybridized_VBN with_IN radiolabeled_JJ DNA_NN probes_NNS for_IN cellular_JJ genes_NNS ._SENT Neurons_NNS were_VBD identified_VBN morphologically_RB by_IN their_PP$ large_JJ size_NN and_CC staining_VBG pattern_NN ._SENT (_( A_NP )_) Muscarinic_NP acetylcholine_NN receptor_NN gene_NN (_( Chrm1_NP )_) ._SENT Grains_NNS indicate_VBP nuclear_JJ and_CC cytoplasmic_JJ distribution_NN of_IN the_DT mRNA_NN in_IN neurons_NNS (_( magnification_NN ,_, x200_NP )_) ._SENT (_( B_NP )_) Protein_NP tyrosine_NN phosphatase_NN sigma_NN gene_NN (_( Ptprs_NN )_) ._SENT Grains_NNS cluster_VBP over_RP neurons_NNS (_( magnification_NN ,_, x400_NP )_) ._SENT Quantitative_JJ real-time_JJ RNA_NP PCR_NP ._SENT Quantitative_JJ real-time_JJ RNA_NP PCR_NP ._SENT This_DT example_NN illustrates_VBZ that_IN the_DT level_NN of_IN Stat1_NP RNA_NP normalized_VBD to_TO Gapdh_NP RNA_NP is_VBZ higher_JJR in_IN latently_RB infected_JJ ganglia_NNS (_( HSV_NP )_) than_IN in_IN mock-infected_JJ ganglia_NNS (_( Mock_NP )_) ._SENT DeltaRn_NP ,_, fluorescence_NN difference_NN from_IN background_NN determined_VBN by_IN using_VBG Sequence_NP Detection_NP System_NP software_NN (_( Applied_NP Biosystems_NP )_) ._SENT Each_DT assay_NN was_VBD performed_VBN in_IN triplicate_NN ._SENT The_DT relative_JJ level_NN of_IN Stat1_NP was_VBD determined_VBN by_IN the_DT difference_NN in_IN average_JJ cycle_NN number_NN at_IN a_DT constant_JJ threshold_NN DeltaRn_NP ._SENT Gapdh_NP ,_, mouse_NN Gapdh_NP mRNA_NP ;_: Stat1_NP ,_, mouse_NN Stat1_NP mRNA_NP ._SENT View_NN is_VBZ expanded_VBN around_IN exponential_JJ phase_NN ._SENT Kinetic_JJ expression_NN profiles_NNS of_IN selected_JJ genes_NNS whose_WP$ up-regulation_NN at_IN day_NN 30_CD p._NN Kinetic_NP expression_NN profiles_NNS of_IN selected_JJ genes_NNS whose_WP$ up-regulation_NN at_IN day_NN 30_CD p.i._NN correlated_VBN significantly_RB with_IN HSV_NP latency_NN ._SENT HSV/Mock_NP ,_, ratios_NNS of_IN mean_JJ normalized_VBN signal_NN intensities_NNS in_IN HSV-infected_JJ samples_NNS to_TO those_DT in_IN mock-infected_JJ samples._NN ._SENT Each_DT bar_NN for_IN day_NN 3_CD or_CC 10_CD p.i._NN represents_VBZ an_DT average_JJ ratio_NN from_IN one_CD experiment_NN ,_, and_CC each_DT bar_NN for_IN day_NN 30_CD p.i._NN represents_VBZ average_JJ ratios_NNS from_IN all_DT three_CD experiments_NNS ._SENT Changes_NNS in_IN mRNA_NN levels_NNS during_IN latent_JJ HSV_NP infection_NN following_VBG peak_JJ expression_NN during_IN acute_JJ infection_NN Changes_NP in_IN mRNA_NN levels_NNS associated_VBN with_IN latent_JJ HSV_NP infection_NN 